Image: Alyson Martin

Federal Cannabis Review Reaches Milestone as HHS Recommends Schedule III Reclassification

The scheduling review, prompted by Pres. Biden in October, could reshape the cannabis policy landscape in the U.S. Now, the DEA will decide.

Regulation
Congress, Newsletter

Outgoing Rep. Blumenauer Talks Banking, Hemp, and Trump

An excerpt from the Cannabis Wire Daily newsletter.

Newsletter, Regulation

Who’s Calling for a Hearing on Rescheduling?

An excerpt from the Cannabis Wire Daily newsletter.